Zensights   Q2 2024 Market Update

Zensights Q2 2024 Market Update

The latest insights on M&A activity in life sciences commercial vendors As part of our LINX bio-pharma vendor review, Zensights is pleased to share an update on merger activity to help our clients understand the market activity that may impact their supplier...
Zensights   Q1 2024 Market Update

Zensights Q1 2024 Market Update

The latest insights on M&A activity in life sciences commercial vendors As part of our LINX bio-pharma vendor review, Zensights is pleased to share an update on merger activity to help our clients understand the market activity that may impact their supplier...
Zensights Q4 2023 Market Update

Zensights Q4 2023 Market Update

The latest insights on M&A activity in life sciences commercial vendors As part of our LINX bio-pharma vendor review, Zensights is pleased to share an update on merger activity to help our clients understand the market activity that may impact their supplier...
Navigating the Veeva-Salesforce Breakup

Navigating the Veeva-Salesforce Breakup

In a significant announcement, Veeva has communicated its decision not to renewits partnership agreement with SalesForce (SFdC) effective September 2025. This development prompts businesses to consider the implications and chart a course forward. While customers are...
Zensights Market Update – November 2023

Zensights Market Update – November 2023

The latest insights on M&A activity in the life sciences commercial vendors As part of our LINX bio-pharma vendor review, Zensights is pleased to share an update on merger activity to help our clients understand the market activity that may impact their supplier...
Zensights Market Update – August 2023

Zensights Market Update – August 2023

The latest insights on M&A activity in the life sciences commercial vendors As part of our LINX bio-pharma vendor review, Zensights is pleased to share an update on merger activity to help our clients understand the market activity that may impact their supplier...